020 3313 3271

Averil Henry, secretary


Healthcare associated infections, C. difficile, tuberculosis

Research & publications

Venanzio V, Gharbi M, Moore LS, Robotham J, Davies F, Brannigan E, Galletly T, Holmes AH, 2015, Screening suspected cases for carbapenemase-producing Enterobacteriaceae, inclusion criteria and demand, J Infect, Jun 10. pii: S0163-4453(15)00197-8. PMID: 26070742

Gharbi M, Moore LS, Gilchrist M, Thomas CP, Bamford K, Brannigan ET, Holmes AH, 2015, Forecasting carbapenem resistance from antimicrobial consumption surveillance: Lessons learnt from an OXA-48-producing Klebsiella pneumoniae outbreak in a West London renal unit, Int J Antimicrob Agents, Aug;46(2):150-6. Epub 2015 Apr 23. PMID: 25979640

Moore LS, Freeman R, Gilchrist MJ, Gharbi M, Brannigan ET, Donaldson H, Livermore DM, Holmes AH, 2014, Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108,717 clinical isolates from primary, secondary and tertiary care patients in London, J Antimicrob Chemother, Dec;69(12):3409-22. Epub 2014 Aug 12. PMID: 25118270

Adler H, De Gascun CF, McSweeney F, Acheson RW, Brannigan ET, Duffy M, Keegan DJ, Lambert JS, 2014, Management of ganciclovir-resistant cytomegalovirus retinitis in HIV infection in the era of antiretroviral therapy, Int J STD AIDS, Oct;25(11):827-9. Epub 2014 Feb 10. PMID: 24516078

Charani E, Kyratsis Y, Lawson W, Wickens H, Brannigan ET, Moore LS, Holmes AH, 2013 An analysis of the development and implementation of a smartphone application for the delivery of antimicrobial prescribing policy: lessons learnt, Apr;68(4):960-7. Epub 2012 Dec 19. PMID: 23258314